Skip to main content

Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Citation
Chakraborty, S., et al. “Metabolites And Hypertension: Insights Into Hypertension As A Metabolic Disorder: 2019 Harriet Dustan Award.”. Hypertension (Dallas, Tex. : 1979), pp. 1386-1396.
Center University of Michigan
Author Saroj Chakraborty, Juthika Mandal, Tao Yang, Xi Cheng, Ji-Youn Yeo, Cameron G McCarthy, Camilla F Wenceslau, Lauren G Koch, Jennifer W Hill, Matam Vijay-Kumar, Bina Joe
Keywords blood pressure, Cardiovascular disease, hypertension, hyperuricemia, mitochondria
Abstract

For over 100 years, essential hypertension has been researched from different perspectives ranging from genetics, physiology, and immunology to more recent ones encompassing microbiology (microbiota) as a previously underappreciated field of study contributing to the cause of hypertension. Each field of study in isolation has uniquely contributed to a variety of underlying mechanisms of blood pressure regulation. Even so, clinical management of essential hypertension has remained somewhat static. We, therefore, asked if there are any converging lines of evidence from these individual fields that could be amenable for a better clinical prognosis. Accordingly, here we present converging evidence which support the view that metabolic dysfunction underlies essential hypertension.

Year of Publication
2020
Journal
Hypertension (Dallas, Tex. : 1979)
Volume
75
Issue
6
Number of Pages
1386-1396
Date Published
06/2020
ISSN Number
1524-4563
DOI
10.1161/HYPERTENSIONAHA.120.13896
Alternate Journal
Hypertension
PMID
32336227
PMCID
PMC7225070
Download citation